幹細胞及び初代細胞培養培地の世界市場2020-2026:リキッドメディア、パウダーメディア

QYResearchが発行した調査報告書(QYR20AP11877)
◆英語タイトル:Global Stem Cell and Primary Cell Culture Medium Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
◆商品コード:QYR20AP11877
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年3月(※2024年版があります。お問い合わせください。)
◆ページ数:141
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD5,600 ⇒換算¥828,800見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD8,400 ⇒換算¥1,243,200見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD11,200 ⇒換算¥1,657,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当リサーチレポートでは、幹細胞及び初代細胞培養培地の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、幹細胞及び初代細胞培養培地のグローバル市場動向、主要メーカー別の市場シェア、種類別市場規模(リキッドメディア、パウダーメディア)、用途別市場規模(バイオ医薬品製造、組織工学・再生医療、遺伝子治療、その他)、地域別(北米、ヨーロッパ、中国、日本)生産規模、地域別(北米、ヨーロッパ、アジア、中南米、中東・アフリカ)消費規模、バリューチェーン、販売チャネル、市場機会・課題・市場環境分析、関連企業情報などを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別市場シェア
・幹細胞及び初代細胞培養培地の種類別市場予測2015-2026:リキッドメディア、パウダーメディア
・幹細胞及び初代細胞培養培地の用途別市場予測2015-2026:バイオ医薬品製造、組織工学・再生医療、遺伝子治療、その他
・幹細胞及び初代細胞培養培地の地域別生産規模2015-2026:北米、ヨーロッパ、中国、日本
・幹細胞及び初代細胞培養培地の地域別消費規模2015-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・関連企業情報:Merck、STEMCELL Technologies、Irvinesci、Cell Applications, Inc、Biological Industries、Miltenyi Biotec、Swiss Medica Clinic、Promocell、Creative Biolabs、Lifeline Cell Technology、ScienCell Research Laboratories、Osiris Therapeutics、NuVasive、Chiesi Pharmaceuticals、JCR Pharmaceutical、Pharmicell、Medi-post、Anterogen、Molmed、Takeda (TiGenix)
・幹細胞及び初代細胞培養培地の地域別生産規模予測2021-2026:北米、ヨーロッパ、中国、日本
・幹細胞及び初代細胞培養培地の地域別消費規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・バリューチェーン及び販売チャネル分析
・市場機会・課題・市場環境分析
・結論
【レポートの概要】

Stem Cells are a class of cells that have unlimited or immortal self-renewal ability, capable of producing at least one type of highly differentiated progeny cells. Primary Cells are cells that are cultured immediately after removal from the body. Stem Cell and Primary Cell Cultures are specialized systems, and as such developing and manufacturing media for these systems come with inherent complexities.The Stem Cell and Primary Cell Culture Medium market was valued at US$ xx Million in 2019 and is projected to reach US$ xx Million by 2026, at a CAGR of xx% during the forecast period. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Stem Cell and Primary Cell Culture Medium.

In terms of production side, this report researches the Stem Cell and Primary Cell Culture Medium capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Stem Cell and Primary Cell Culture Medium by regions (countries) and application.
The global Stem Cell and Primary Cell Culture Medium market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Stem Cell and Primary Cell Culture Medium market. These figures have been provided in terms of both revenue and volume for the period 2015-2026. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Stem Cell and Primary Cell Culture Medium markets such as the U.S., Canada, Germany, France, the U.K., Italy, Russia, China, Japan, South Korea, Taiwan, India, the Philippines, Malaysia, Thailand, Indonesia, Vietnam Australia, Mexico, Brazil, Saudi Arabia, the UAE and Turkey etc. Key regions covered in the report are North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
For the period 2015-2026, the report provides country-wise revenue and production capacity analysis and region-wise revenue and volume analysis of the global Stem Cell and Primary Cell Culture Medium market. For the period 2015-2020, it provides consumption (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation
The report includes a detailed analysis of leading and by Type and by Application segments of the global Stem Cell and Primary Cell Culture Medium market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers value, volume analysis and forecast of the global Stem Cell and Primary Cell Culture Medium market by Type and by Application segment for the period 2015-2026.
Segment by Type, the Stem Cell and Primary Cell Culture Medium market is segmented into
Liquid Media
Powder Media

Segment by Application, the Stem Cell and Primary Cell Culture Medium market is segmented into
Biopharmaceutical Manufacturing
Tissue Engineering & Regenerative Medicine
Gene Therapy
Other
Competitive Landscape and Stem Cell and Primary Cell Culture Medium Market Share Analysis
Stem Cell and Primary Cell Culture Medium market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, revenue and price by the player for the period 2015-2020. Details included are company description, major businesses, company total revenue and the production capacity, revenue generated in Stem Cell and Primary Cell Culture Medium business, competitors, the date to enter into the Stem Cell and Primary Cell Culture Medium market, Stem Cell and Primary Cell Culture Medium product introduction, recent developments, etc.

The major vendors covered:
Merck
STEMCELL Technologies
Irvinesci
Cell Applications, Inc
Biological Industries
Miltenyi Biotec
Swiss Medica Clinic
Promocell
Creative Biolabs
Lifeline Cell Technology
ScienCell Research Laboratories
Osiris Therapeutics
NuVasive
Chiesi Pharmaceuticals
JCR Pharmaceutical
Pharmicell
Medi-post
Anterogen
Molmed
Takeda (TiGenix)

The study objectives are:
To analyze and research the global Stem Cell and Primary Cell Culture Medium status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Stem Cell and Primary Cell Culture Medium manufacturers, capacity, production, revenue, market share, and recent development.
To split the breakdown data by regions, type, manufacturers and application.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Stem Cell and Primary Cell Culture Medium are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Stem Cell and Primary Cell Culture Medium Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Stem Cell and Primary Cell Culture Medium Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Liquid Media
1.3.3 Powder Media
1.4 Market Segment by Application
1.4.1 Global Stem Cell and Primary Cell Culture Medium Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Biopharmaceutical Manufacturing
1.4.3 Tissue Engineering & Regenerative Medicine
1.4.4 Gene Therapy
1.4.5 Other
1.5 Study Objectives
1.6 Years Considered

2 Global Market Perspective
2.1 Global Stem Cell and Primary Cell Culture Medium Production Capacity Analysis
2.1.1 Global Stem Cell and Primary Cell Culture Medium Production Value (2015-2026)
2.1.2 Global Stem Cell and Primary Cell Culture Medium Production (2015-2026)
2.1.3 Global Stem Cell and Primary Cell Culture Medium Capacity (2015-2026)
2.1.4 Global Stem Cell and Primary Cell Culture Medium Marketing Pricing and Trends
2.2 Global Stem Cell and Primary Cell Culture Medium Market Size Growth Potential by Key Producing Regions
2.2.1 Global Stem Cell and Primary Cell Culture Medium Market Size by Key Producing Regions: 2015 VS 2021 VS 2026
2.2.2 Global Stem Cell and Primary Cell Culture Medium Market Share by Key Producing Regions: 2021 VS 2026
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Primary Interviews with Key Stem Cell and Primary Cell Culture Medium Players: Views for Future

3 Market Share by Manufacturers
3.1 Global Top Manufacturers by Stem Cell and Primary Cell Culture Medium Production Capacity
3.1.1 Global Top Manufacturers by Stem Cell and Primary Cell Culture Medium Production Capacity (2015-2020)
3.1.2 Global Top Manufacturers by Stem Cell and Primary Cell Culture Medium Production (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Stem Cell and Primary Cell Culture Medium Production in 2019
3.2 Global Top Manufacturers by Stem Cell and Primary Cell Culture Medium Revenue
3.2.1 Global Top Manufacturers by Stem Cell and Primary Cell Culture Medium Revenue (2015-2020)
3.2.2 Global Top Manufacturers Market Share by Stem Cell and Primary Cell Culture Medium Revenue (2015-2020)
3.2.3 Global Stem Cell and Primary Cell Culture Medium Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stem Cell and Primary Cell Culture Medium as of 2019)
3.4 Global Stem Cell and Primary Cell Culture Medium Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Stem Cell and Primary Cell Culture Medium Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Stem Cell and Primary Cell Culture Medium Market
3.7 Key Manufacturers Stem Cell and Primary Cell Culture Medium Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Estimate and Forecast by Type (2015-2026)
4.1 Global Stem Cell and Primary Cell Culture Medium Historic Market Size by Type (2015-2020)
4.1.2 Global Stem Cell and Primary Cell Culture Medium Production Market Share by Type (2015-2020)
4.1.3 Global Stem Cell and Primary Cell Culture Medium Production Value Market Share by Type
4.1.4 Stem Cell and Primary Cell Culture Medium Average Selling Price (ASP) by Type (2015-2020)
4.2 Global Stem Cell and Primary Cell Culture Medium Market Size Forecast by Type (2021-2026)
4.2.2 Global Stem Cell and Primary Cell Culture Medium Production Market Share Forecast by Type (2021-2026)
4.2.3 Global Stem Cell and Primary Cell Culture Medium Production Value Market Share Forecast by Type
4.2.4 Stem Cell and Primary Cell Culture Medium Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Stem Cell and Primary Cell Culture Medium Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Stem Cell and Primary Cell Culture Medium Consumption by Application (2015-2020)
5.2 Global Stem Cell and Primary Cell Culture Medium Consumption by Application (2021-2026)

6 Production by Regions: Market Fact & Figures
6.1 Global Stem Cell and Primary Cell Culture Medium Production (History Data) by Regions (2015-2020)
6.2 Global Stem Cell and Primary Cell Culture Medium Production Value (History Data) by Regions
6.3 North America
6.3.1 North America Stem Cell and Primary Cell Culture Medium Production Growth Rate (2015-2020)
6.3.2 North America Stem Cell and Primary Cell Culture Medium Production Value Growth Rate (2015-2020)
6.3.3 Key Players Market Share in North America
6.3.4 North America Stem Cell and Primary Cell Culture Medium Import & Export (2015-2020)
6.4 Europe
6.4.1 Europe Stem Cell and Primary Cell Culture Medium Production Growth Rate (2015-2020)
6.4.2 Europe Stem Cell and Primary Cell Culture Medium Production Value Growth Rate (2015-2020)
6.4.3 Key Players Market Share in Europe
6.4.4 Europe Stem Cell and Primary Cell Culture Medium Import & Export (2015-2020)
6.5 China
6.5.1 China Stem Cell and Primary Cell Culture Medium Production Growth Rate (2015-2020)
6.5.2 China Stem Cell and Primary Cell Culture Medium Production Value Growth Rate (2015-2020)
6.5.3 Key Players Market Share in China
6.5.4 China Stem Cell and Primary Cell Culture Medium Import & Export (2015-2020)
6.6 Japan
6.6.1 Japan Stem Cell and Primary Cell Culture Medium Production Growth Rate (2015-2020)
6.6.2 Japan Stem Cell and Primary Cell Culture Medium Production Value Growth Rate (2015-2020)
6.6.3 Key Players Market Share in Japan
6.6.4 Japan Stem Cell and Primary Cell Culture Medium Import & Export (2015-2020)

7 Stem Cell and Primary Cell Culture Medium Consumption by Regions: Market Fact & Figures
7.1 Global Stem Cell and Primary Cell Culture Medium Consumption (History Data) by Regions (2015-2020)
7.2 Global Top Stem Cell and Primary Cell Culture Medium Consumers (regions/countries) Ranking and Share of Total Stem Cell and Primary Cell Culture Medium Consumption in 2015 VS 2019
7.3 North America
7.3.1 North America Stem Cell and Primary Cell Culture Medium Consumption by Type
7.3.2 North America Stem Cell and Primary Cell Culture Medium Consumption by Application
7.3.3 North America Stem Cell and Primary Cell Culture Medium Consumption by Countries
7.3.4 U.S.
7.3.5 Canada
7.4 Europe
7.4.1 Europe Stem Cell and Primary Cell Culture Medium Consumption by Type
7.4.2 Europe Stem Cell and Primary Cell Culture Medium Consumption by Application
7.4.3 Europe Stem Cell and Primary Cell Culture Medium Consumption by Countries
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
7.5 Asia Pacific
7.5.1 Asia Pacific Stem Cell and Primary Cell Culture Medium Consumption by Type
7.5.2 Asia Pacific Stem Cell and Primary Cell Culture Medium Consumption by Application
7.5.3 Asia Pacific Stem Cell and Primary Cell Culture Medium Consumption by Regions
7.5.4 China
7.5.5 Japan
7.5.6 South Korea
7.5.7 India
7.5.8 Australia
7.5.9 Taiwan
7.5.10 Indonesia
7.5.11 Thailand
7.5.12 Malaysia
7.5.13 Philippines
7.5.14 Vietnam
7.6 Central & South America
7.6.1 Central & South America Stem Cell and Primary Cell Culture Medium Consumption by Type
7.6.2 Central & South America Stem Cell and Primary Cell Culture Medium Consumption by Application
7.6.3 Central & South America Stem Cell and Primary Cell Culture Medium Consumption by Countries
7.6.4 Mexico
7.6.5 Brazil
7.6.6 Argentina
7.7 Middle East and Africa
7.7.1 Middle East and Africa Stem Cell and Primary Cell Culture Medium Consumption by Type
7.7.2 Middle East and Africa Stem Cell and Primary Cell Culture Medium Consumption by Application
7.7.3 Central & South America Stem Cell and Primary Cell Culture Medium Consumption by Countries
7.7.4 Turkey
7.7.5 Saudi Arabia
7.7.6 U.A.E

8 Company Profiles
8.1 Merck
8.1.1 Merck Corporation Information
8.1.2 Merck Business Overview and Total Revenue (2019 VS 2018)
8.1.3 Merck Stem Cell and Primary Cell Culture Medium Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.1.4 Stem Cell and Primary Cell Culture Medium Products and Services
8.1.5 Merck SWOT Analysis
8.1.6 Merck Recent Developments
8.2 STEMCELL Technologies
8.2.1 STEMCELL Technologies Corporation Information
8.2.2 STEMCELL Technologies Business Overview and Total Revenue (2019 VS 2018)
8.2.3 STEMCELL Technologies Stem Cell and Primary Cell Culture Medium Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.2.4 Stem Cell and Primary Cell Culture Medium Products and Services
8.2.5 STEMCELL Technologies SWOT Analysis
8.2.6 STEMCELL Technologies Recent Developments
8.3 Irvinesci
8.3.1 Irvinesci Corporation Information
8.3.2 Irvinesci Business Overview and Total Revenue (2019 VS 2018)
8.3.3 Irvinesci Stem Cell and Primary Cell Culture Medium Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.3.4 Stem Cell and Primary Cell Culture Medium Products and Services
8.3.5 Irvinesci SWOT Analysis
8.3.6 Irvinesci Recent Developments
8.4 Cell Applications, Inc
8.4.1 Cell Applications, Inc Corporation Information
8.4.2 Cell Applications, Inc Business Overview and Total Revenue (2019 VS 2018)
8.4.3 Cell Applications, Inc Stem Cell and Primary Cell Culture Medium Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.4.4 Stem Cell and Primary Cell Culture Medium Products and Services
8.4.5 Cell Applications, Inc SWOT Analysis
8.4.6 Cell Applications, Inc Recent Developments
8.5 Biological Industries
8.5.1 Biological Industries Corporation Information
8.5.2 Biological Industries Business Overview and Total Revenue (2019 VS 2018)
8.5.3 Biological Industries Stem Cell and Primary Cell Culture Medium Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.5.4 Stem Cell and Primary Cell Culture Medium Products and Services
8.5.5 Biological Industries SWOT Analysis
8.5.6 Biological Industries Recent Developments
8.6 Miltenyi Biotec
8.6.1 Miltenyi Biotec Corporation Information
8.6.3 Miltenyi Biotec Stem Cell and Primary Cell Culture Medium Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.6.3 Miltenyi Biotec Stem Cell and Primary Cell Culture Medium Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.6.4 Stem Cell and Primary Cell Culture Medium Products and Services
8.6.5 Miltenyi Biotec SWOT Analysis
8.6.6 Miltenyi Biotec Recent Developments
8.7 Swiss Medica Clinic
8.7.1 Swiss Medica Clinic Corporation Information
8.7.2 Swiss Medica Clinic Business Overview and Total Revenue (2019 VS 2018)
8.7.3 Swiss Medica Clinic Stem Cell and Primary Cell Culture Medium Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.7.4 Stem Cell and Primary Cell Culture Medium Products and Services
8.7.5 Swiss Medica Clinic SWOT Analysis
8.7.6 Swiss Medica Clinic Recent Developments
8.8 Promocell
8.8.1 Promocell Corporation Information
8.8.2 Promocell Business Overview and Total Revenue (2019 VS 2018)
8.8.3 Promocell Stem Cell and Primary Cell Culture Medium Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.8.4 Stem Cell and Primary Cell Culture Medium Products and Services
8.8.5 Promocell SWOT Analysis
8.8.6 Promocell Recent Developments
8.9 Creative Biolabs
8.9.1 Creative Biolabs Corporation Information
8.9.2 Creative Biolabs Business Overview and Total Revenue (2019 VS 2018)
8.9.3 Creative Biolabs Stem Cell and Primary Cell Culture Medium Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.9.4 Stem Cell and Primary Cell Culture Medium Products and Services
8.9.5 Creative Biolabs SWOT Analysis
8.9.6 Creative Biolabs Recent Developments
8.10 Lifeline Cell Technology
8.10.1 Lifeline Cell Technology Corporation Information
8.10.2 Lifeline Cell Technology Business Overview and Total Revenue (2019 VS 2018)
8.10.3 Lifeline Cell Technology Stem Cell and Primary Cell Culture Medium Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.10.4 Stem Cell and Primary Cell Culture Medium Products and Services
8.10.5 Lifeline Cell Technology SWOT Analysis
8.10.6 Lifeline Cell Technology Recent Developments
8.11 ScienCell Research Laboratories
8.11.1 ScienCell Research Laboratories Corporation Information
8.11.2 ScienCell Research Laboratories Business Overview and Total Revenue (2019 VS 2018)
8.11.3 ScienCell Research Laboratories Stem Cell and Primary Cell Culture Medium Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.11.4 Stem Cell and Primary Cell Culture Medium Products and Services
8.11.5 ScienCell Research Laboratories SWOT Analysis
8.11.6 ScienCell Research Laboratories Recent Developments
8.12 Osiris Therapeutics
8.12.1 Osiris Therapeutics Corporation Information
8.12.2 Osiris Therapeutics Business Overview and Total Revenue (2019 VS 2018)
8.12.3 Osiris Therapeutics Stem Cell and Primary Cell Culture Medium Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.12.4 Stem Cell and Primary Cell Culture Medium Products and Services
8.12.5 Osiris Therapeutics SWOT Analysis
8.12.6 Osiris Therapeutics Recent Developments
8.13 NuVasive
8.13.1 NuVasive Corporation Information
8.13.2 NuVasive Business Overview and Total Revenue (2019 VS 2018)
8.13.3 NuVasive Stem Cell and Primary Cell Culture Medium Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.13.4 Stem Cell and Primary Cell Culture Medium Products and Services
8.13.5 NuVasive SWOT Analysis
8.13.6 NuVasive Recent Developments
8.14 Chiesi Pharmaceuticals
8.14.1 Chiesi Pharmaceuticals Corporation Information
8.14.2 Chiesi Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
8.14.3 Chiesi Pharmaceuticals Stem Cell and Primary Cell Culture Medium Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.14.4 Stem Cell and Primary Cell Culture Medium Products and Services
8.14.5 Chiesi Pharmaceuticals SWOT Analysis
8.14.6 Chiesi Pharmaceuticals Recent Developments
8.15 JCR Pharmaceutical
8.15.1 JCR Pharmaceutical Corporation Information
8.15.2 JCR Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)
8.15.3 JCR Pharmaceutical Stem Cell and Primary Cell Culture Medium Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.15.4 Stem Cell and Primary Cell Culture Medium Products and Services
8.15.5 JCR Pharmaceutical SWOT Analysis
8.15.6 JCR Pharmaceutical Recent Developments
8.16 Pharmicell
8.16.1 Pharmicell Corporation Information
8.16.2 Pharmicell Business Overview and Total Revenue (2019 VS 2018)
8.16.3 Pharmicell Stem Cell and Primary Cell Culture Medium Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.16.4 Stem Cell and Primary Cell Culture Medium Products and Services
8.16.5 Pharmicell SWOT Analysis
8.16.6 Pharmicell Recent Developments
8.17 Medi-post
8.17.1 Medi-post Corporation Information
8.17.2 Medi-post Business Overview and Total Revenue (2019 VS 2018)
8.17.3 Medi-post Stem Cell and Primary Cell Culture Medium Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.17.4 Stem Cell and Primary Cell Culture Medium Products and Services
8.17.5 Medi-post SWOT Analysis
8.17.6 Medi-post Recent Developments
8.18 Anterogen
8.18.1 Anterogen Corporation Information
8.18.2 Anterogen Business Overview and Total Revenue (2019 VS 2018)
8.18.3 Anterogen Stem Cell and Primary Cell Culture Medium Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.18.4 Stem Cell and Primary Cell Culture Medium Products and Services
8.18.5 Anterogen SWOT Analysis
8.18.6 Anterogen Recent Developments
8.19 Molmed
8.19.1 Molmed Corporation Information
8.19.2 Molmed Business Overview and Total Revenue (2019 VS 2018)
8.19.3 Molmed Stem Cell and Primary Cell Culture Medium Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.19.4 Stem Cell and Primary Cell Culture Medium Products and Services
8.19.5 Molmed SWOT Analysis
8.19.6 Molmed Recent Developments
8.20 Takeda (TiGenix)
8.20.1 Takeda (TiGenix) Corporation Information
8.20.2 Takeda (TiGenix) Business Overview and Total Revenue (2019 VS 2018)
8.20.3 Takeda (TiGenix) Stem Cell and Primary Cell Culture Medium Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.20.4 Stem Cell and Primary Cell Culture Medium Products and Services
8.20.5 Takeda (TiGenix) SWOT Analysis
8.20.6 Takeda (TiGenix) Recent Developments

9 Stem Cell and Primary Cell Culture Medium Production Side by Producing Regions (Countries)
9.1 Global Stem Cell and Primary Cell Culture Medium Production Value Forecast by Region (2021-2026)
9.2 Stem Cell and Primary Cell Culture Medium Production Forecast by Regions
9.3 Key Stem Cell and Primary Cell Culture Medium Producing Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan

10 Stem Cell and Primary Cell Culture Medium Consumption Forecast by Top Consumers (Regions/Countries)
10.1 Global Stem Cell and Primary Cell Culture Medium Consumption Forecast by Region (2021-2026)
10.2 North America Market Consumption YoY Growth Forecast
10.2.1 North America Stem Cell and Primary Cell Culture Medium Consumption YoY Growth (2021-2026)
10.2.2 North America Stem Cell and Primary Cell Culture Medium Consumption Forecast by Country (2021-2026)
10.3 Europe Market Consumption YoY Growth Forecast
10.3.1 Europe Stem Cell and Primary Cell Culture Medium Consumption YoY Growth (2021-2026)
10.3.2 Europe Stem Cell and Primary Cell Culture Medium Consumption Forecast by Country (2021-2026)
10.4 Asia Pacific Market Consumption YoY Growth Forecast
10.4.1 Asia Pacific Stem Cell and Primary Cell Culture Medium Consumption YoY Growth (2021-2026)
10.4.1 Asia Pacific Stem Cell and Primary Cell Culture Medium Consumption Forecast by Regions (2021-2026)
10.5 Latin America Market Consumption YoY Growth Forecast
10.5.1 Latin America Stem Cell and Primary Cell Culture Medium Consumption YoY Growth (2021-2026)
10.5.2 Latin America Stem Cell and Primary Cell Culture Medium Consumption Forecast by Country (2021-2026)
10.6 Middle East and Africa Market Consumption YoY Growth Forecast
10.6.1 Middle East and Africa Stem Cell and Primary Cell Culture Medium Consumption YoY Growth (2021-2026)
10.6.2 Middle East and Africa Stem Cell and Primary Cell Culture Medium Consumption Forecast by Country (2021-2026)

11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Stem Cell and Primary Cell Culture Medium Sales Channels
11.2.2 Stem Cell and Primary Cell Culture Medium Distributors
11.3 Stem Cell and Primary Cell Culture Medium Customers

12 Opportunities & Challenges, Threat and Affecting Factors
12.1 Market Opportunities
12.2 Market Challenges
12.3 Porter’s Five Forces Analysis

13 Key Findings

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

...

【掲載企業】

Merck、STEMCELL Technologies、Irvinesci、Cell Applications, Inc、Biological Industries、Miltenyi Biotec、Swiss Medica Clinic、Promocell、Creative Biolabs、Lifeline Cell Technology、ScienCell Research Laboratories、Osiris Therapeutics、NuVasive、Chiesi Pharmaceuticals、JCR Pharmaceutical、Pharmicell、Medi-post、Anterogen、Molmed、Takeda (TiGenix)

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 幹細胞及び初代細胞培養培地の世界市場2020-2026:リキッドメディア、パウダーメディア(Global Stem Cell and Primary Cell Culture Medium Industry Research Report, Growth Trends and Competitive Analysis 2020-2026)]についてメールでお問い合わせはこちらでお願いします。